184 related articles for article (PubMed ID: 25672787)
1. Cosmetovigilance: definition, regulation and use "in practice".
Vigan M; Castelain F
Eur J Dermatol; 2014; 24(6):643-9. PubMed ID: 25672787
[TBL] [Abstract][Full Text] [Related]
2. A cosmetovigilance survey in Europe.
Sautebin L
Pharmacol Res; 2007 May; 55(5):455-60. PubMed ID: 17368906
[TBL] [Abstract][Full Text] [Related]
3. [Cosmetovigilance: a French pharmacovigilance system for cosmetics developed by the French health products safety agency. A proposal for the future].
Tissier MH; Lepagnol F
Therapie; 2002; 57(3):273-82. PubMed ID: 12422542
[TBL] [Abstract][Full Text] [Related]
4. Causality methods in cosmetovigilance: comparison of Colipa and PLM versus global introspection.
Zweers PG; Gilmour NJ; Hepburn PA; Gerritsen RF; van Puijenbroek EP
Regul Toxicol Pharmacol; 2012 Aug; 63(3):409-17. PubMed ID: 22609380
[TBL] [Abstract][Full Text] [Related]
5. Assessment of undesirable events in cosmetic market surveillance: background, description and use of a causality assessment method in cosmetovigilance.
Bons B; Audebert F; Bitaudeau C; Cachin N; Colson L; Farr C; Fix LA; Gilmour N; Gorni R; Griffiths M; Harris B; Holle V; Kirk S; Meredith E; Pari C; Poinsot P; Renner G;
Regul Toxicol Pharmacol; 2010 Dec; 58(3):349-53. PubMed ID: 20619309
[No Abstract] [Full Text] [Related]
6. Safety in Cosmetics and Cosmetovigilance, Current Regulations in Türkiye.
Altıokka İ; Üner M
Turk J Pharm Sci; 2022 Oct; 19(5):610-617. PubMed ID: 36317955
[TBL] [Abstract][Full Text] [Related]
7. Changes in European legislation make it timely to introduce a transparent market surveillance system for cosmetics.
Lodén M; Ungerth L; Serup J
Acta Derm Venereol; 2007; 87(6):485-92. PubMed ID: 17989885
[TBL] [Abstract][Full Text] [Related]
8. Cosmetovigilance: the 'beautiful' risk.
Moretti U; Velo G
Drug Saf; 2008; 31(5):437-9. PubMed ID: 18422387
[TBL] [Abstract][Full Text] [Related]
9. [Phytovigilance: A medical requirement and a legal obligation].
Lehmann H; Pabst JY
Ann Pharm Fr; 2016 Jan; 74(1):49-60. PubMed ID: 26210820
[TBL] [Abstract][Full Text] [Related]
10. [Cosmetic products : Safety aspects].
Platzek T; Krätke R; Schulz C
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jun; 53(6):610-4. PubMed ID: 20464352
[TBL] [Abstract][Full Text] [Related]
11. Cosmetovigilance: A review of the current literature.
Toklu HZ; Antigua A; Lewis V; Reynolds M; Jones J
J Family Med Prim Care; 2019 May; 8(5):1540-1545. PubMed ID: 31198710
[TBL] [Abstract][Full Text] [Related]
12. Understanding the adverse effects of cosmetics: a pilot project in cosmetovigilance.
Sautebin L
Drug Saf; 2008; 31(5):433-6. PubMed ID: 18422386
[TBL] [Abstract][Full Text] [Related]
13. Cosmetovigilance in a tertiary care hospital: A prospective observational study.
Jyrwa S; Sebastian J; Shastry V
J Cosmet Dermatol; 2021 Mar; 20(3):804-811. PubMed ID: 32808451
[TBL] [Abstract][Full Text] [Related]
14. Notification of undesirable effects of cosmetics and toiletries.
Sportiello L; Cammarota S; de Portu S; Sautebin L
Pharmacol Res; 2009 Feb; 59(2):101-6. PubMed ID: 19028583
[TBL] [Abstract][Full Text] [Related]
15. The reorganisation of European pharmacovigilance. Part 2. From spontaneous reports to agency reviews and decisions.
Prescrire Int; 2015 Feb; 24(157):50-4. PubMed ID: 25802924
[TBL] [Abstract][Full Text] [Related]
16. Surveillance of dermo-cosmetic products: a global cosmetovigilance system to optimise product development and consumer safety.
Ribet V; Albinet Claudin L; Brinio E; Berthier A; Millet V; Halbeher C; Sauvaire L; Laborderie M; Lafosse S; Olivan A; Giordano Labadie F; Ferret PJ
Eur J Dermatol; 2021 Aug; ():. PubMed ID: 34463281
[TBL] [Abstract][Full Text] [Related]
17. Safety evaluation of cosmetics in the EU. Reality and challenges for the toxicologist.
Pauwels M; Rogiers V
Toxicol Lett; 2004 Jun; 151(1):7-17. PubMed ID: 15177635
[TBL] [Abstract][Full Text] [Related]
18. Vigilance in industry: cosmetics and household cleaning products. Balance sheet of case report from 2005 to 2007.
Kornfeld-Lecanu S; Zajaczkowski F; Dubourg S; Martin L; Lefort S; Siest S
Clin Exp Dermatol; 2010 Dec; 35(8):874-80. PubMed ID: 20718782
[TBL] [Abstract][Full Text] [Related]
19. [The European regulation for cosmetics : Legislative aspect from the German point of view].
Butschke A; Dross A
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jun; 53(6):606-9. PubMed ID: 20458455
[TBL] [Abstract][Full Text] [Related]
20. A perspective on the safety of cosmetic products: a position paper of the American Council on Science and Health.
Ross G
Int J Toxicol; 2006; 25(4):269-77. PubMed ID: 16815815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]